1Ambrosy AP, Fonarow GC, Butler J, et al. The Global Health and Econo- mic Burden of Hospitalizations for Heart Failure : Lessons Learned From Hospitalized Heart Failure Registries[J]. J Am Coll Cardiol, 2014,63 ( 12 ) : 1123-1133.
4Gu J, Noe A, Chandra P, et al. Pharmacokinetics and pharmacodynamics of LCZ696,a novel dual-acting angiotensin receptor-neprilysin inhibitor (ARNi) [J]. J Clin Pharmacol, 2010,50 (4) : 401-414.
5Voors AA, Dorhout B, van der Meer P. The potential role of valsartan+ AHU377 (LCZ696) in the treatment of heart failure[J]. Expert Opin In- vestig Drugs ,2013,22(8) : 1041-1047.
6McMurray JJ, Packer M, Desai AS, et al. Dual angiotensin receptor and neprily-sin inhibition as an alternative to angio-tensin-converting enzyme inhibition in patients with chronic systolic heart failure : rationale for and design of the Prospective comparison of ARNI with ACEI to Determine Impact on Global Mortality and morbidity in Heart Failure trial (PARA- DIGM-HF)[J]. Eur J Heart Fail, 2013,15 (3) : 1062-1073.
7de Bold A J, Borenstein HB,Veress AT, et al. A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats[J]. Life Sci, 1981,28 ( 1 ) : 89-94.
8P. Perrone Filardi(ed.). ACEi and ARBS in Hypertension and Heart Failure. Current Cardiovascular Therapy, 2015,5.
9Brandt RR, Redfield MM, Aarhus LL, et al. Clearance receptor-mediated control of atrial natriuretic factor in experimental congestive heart failure[J]. Am J Physiol, 1994,266 (3 Pt 2) : R936-R943.
10Lee ME,Miller WL, Edwards BS,et al. Role of endogenous atrial natriuretic factor in acute congestive heart failure[J]. J Clin Invest, 1989,84 (6): 1962-1966.
6Lopez AD.Assessing the burden of mortaIity from cardiovascuIar diS-eases[J]WorId Health Star Q,1993(02):91-96.
7World health organization.Cardiovascular disease:prevention and control.
8Mendez GF;Cowie MR.The epidemiological features of heart failure in developing countries:a review of the literature[J]International Journal of Cardiology,2001(2-3):213-219.
9Dickstein K;Cohen-Solal A;Filippatos G.ESC Guidelines for the diagnosis and treatment of acute andchronic heart failure 2008 The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology.Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM)</a>[J].European Journal of Heart Failure,2008(10):933-989.
10Roger VL;Weston SA;Redfield MA.Trends in heart failure incidence and survival in a community-based population[J]Journal of the American Medical Association,2004(03):344-350.
